ArticleIntensive care medicine2022
Dose of norepinephrine: the devil is in the details.
Article in Intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Effect of Weight-based versus Absolute Norepinephrine Dosing on Mortality Risk in Obese Patients with Septic Shock: An Observational, Multicohort, Retrospective Study.Anesthesiology · 2026Observational
- Need for standardization in norepinephrine dosage in the management of septic shock.Revista peruana de medicina experimental y salud publica · 2025Article
- Norepinephrine formulation itself does not constitute heterogeneity in shock trials.Critical care (London, England) · 2025Article
- Norepinephrine pharmacolexicology: a chronological review of dose reporting and the implications of salt formulations.Intensive care medicine · 2025Review
- Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?Critical care (London, England) · 2025Review
- Vasopressin use across shock states: international insights from an international ESICM-endorsed survey: the PRESS Survey.Critical care (London, England) · 2025Article
- Hydrocortisone and arginine vasopressin in post-resuscitation shock: the HYVAPRESS trial.Resuscitation plus · 2025Article
- Use of norepinephrine in the pediatric intensive care unit: an international survey of prescription and administration habits in case of pediatric hypotensive shock.European journal of pediatrics · 2025Article
- Effect of early adjunctive vasopressin initiation for septic shock patients: a target trial emulation.Critical care (London, England) · 2025Article
- Haemodynamic management of septic shock.Burns & trauma · 2025Review
- The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients.Critical care (London, England) · 2024Article
- A common data model for the standardization of intensive care unit medication features.JAMIA open · 2024Article
- Norepinephrine dose and concentration reporting: a closer look at the fine print.Intensive care medicine · 2024Article
- Vasopressin in Sepsis and Other Shock States: State of the Art.Journal of personalized medicine · 2023Review
- Norepinephrine dosage: the details go beyond a grain of salt.Intensive care medicine · 2023Article
- When to start vasopressin in septic shock: the strategy we propose.Critical care (London, England) · 2022Article
- Methylene Blue Reduces Fluid Loading and Norepinephrine Requirements for Post-Resuscitation Syndrome in a Pig Model of Refractory Cardiac Arrest Resuscitated with Veno-Arterial ECMO.Journal of clinical medicine · 2022Article
Corrections and comments
- Commented on by
- Commented on by
- Comment on
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
35290485What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.